Nanjing, China

Jianbing Wu

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jianbing Wu in Pharmaceutical Chemistry

Introduction

Jianbing Wu is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating cardiovascular and cerebrovascular diseases. His work focuses on enhancing drug efficacy and safety through innovative chemical formulations.

Latest Patents

Jianbing Wu holds a patent for "Salts formed by 2-(1-acyloxy-n-pentyl) benzoic acid and basic amino acid or aminoguanidine, and preparation method and application thereof." This patent discloses salts formed by the aforementioned compounds, detailing their preparation methods and applications in pharmaceutical formulations. The compounds exhibit excellent water solubility, stability in aqueous solutions, and favorable pharmacokinetic properties. They demonstrate significant anti-platelet aggregation, anti-thrombosis, and neuroprotective activities, proving to be more effective than existing treatments like (S)-butylphthalide.

Career Highlights

Throughout his career, Jianbing Wu has worked with prominent organizations such as Jiangsu Kanion Pharmaceutical Co., Ltd. and China Pharmaceutical University. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.

Collaborations

Jianbing Wu has collaborated with notable colleagues, including Yihua Zhang and Wei Xiao. Their joint efforts have furthered research in the field of pharmaceutical chemistry, leading to advancements in drug development.

Conclusion

Jianbing Wu's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a significant inventor in the field. His work continues to impact the development of effective treatments for critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…